COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Wolfgang Miesbach, Michael Makris

Abstract

The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death in a proportion of patients. Among other factors and direct viral effects, the increase in the vasoconstrictor angiotensin II, the decrease in the vasodilator angiotensin, and the sepsis-induced release of cytokines can trigger a coagulopathy in COVID-19. A coagulopathy has been reported in up to 50% of patients with severe COVID-19 manifestations. An increase in d-dimer is the most significant change in coagulation parameters in severe COVID-19 patients, and progressively increasing values can be used as a prognostic parameter indicating a worse outcome. Limited data suggest a high incidence of deep vein thrombosis and pulmonary embolism in up to 40% of patients, despite the use of a standard dose of low-molecular-weight heparin (LMWH) in most cases. In addition, pulmonary microvascular thrombosis has been reported and may play a role in progressive lung failure. Prophylactic LMWH has been recommended by the International Society on Thrombosis and Haemostasis (ISTH) and the Am...Continue Reading

References

Jan 1, 1995·Journal of Cardiovascular Pharmacology·C DosquetJ L Wautier
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R S Mummery, C C Rider
Jun 21, 2002·Nature·Michael A CrackowerJosef M Penninger
Apr 16, 2003·The New England Journal of Medicine·Nelson LeeJoseph J Y Sung
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Jun 21, 2003·BMJ : British Medical Journal·Raymond S M WongJoseph J Y Sung
Mar 5, 2004·Intensive Care Medicine·C Brun-BuissonUNKNOWN EPISEPSIS Study Group
Oct 27, 2004·Journal of Neurology·T UmapathiSze Peng Brenda Ang
Jun 7, 2005·Postgraduate Medical Journal·K H L NgK Y Yuen
Nov 27, 2010·Expert Review of Cardiovascular Therapy·Alessandro CeliRoberto Pedrinelli
Dec 12, 2012·Nature Reviews. Immunology·Bernd Engelmann, Steffen Massberg
Sep 10, 2013·Antiviral Research·Rolf Hilgenfeld, Malik Peiris
Dec 18, 2013·Virulence·Florian B MayrDerek C Angus
Jun 28, 2016·Nature Reviews. Microbiology·Emmie de WitVincent J Munster
Nov 28, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susan S EllenbergKeith P W J McAdam
Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Feb 17, 2019·The Journal of Surgical Research·Yina LiuXiaochun Ma
May 24, 2019·Germs·Nour Ramadan, Houssam Shaib
Aug 21, 2019·Nature Reviews. Cardiology·Maria Paz OcaranzaSergio Lavandero
Feb 8, 2020·JAMA : the Journal of the American Medical Association·Dawei WangZhiyong Peng
Feb 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Ning TangZiyong Sun
Feb 23, 2020·The Lancet. Respiratory Medicine·Zhe XuFu-Sheng Wang
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 24, 2020·The Lancet. Respiratory Medicine·Shuo FengBenjamin J Cowling
Apr 5, 2020·Journal of Clinical Microbiology·Yi-Wei TangCharles W Stratton
Apr 9, 2020·The New England Journal of Medicine·Yan ZhangShuyang Zhang
Apr 21, 2020·Journal of the American College of Cardiology·Behnood BikdeliUNKNOWN Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working
Apr 24, 2020·Lancet·Zsuzsanna VargaHolger Moch
Apr 28, 2020·Journal of Thrombosis and Haemostasis : JTH·Jecko ThachilToshiaki Iba
May 14, 2020·The New England Journal of Medicine·Victor G PuellesTobias B Huber

❮ Previous
Next ❯

Citations

Aug 28, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Alexandru BurlacuRadu Crisan-Dabija
Oct 21, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Indra WijayaIan Huang
Dec 29, 2020·The Ultrasound Journal·Marta AlfagemeAgustín García Suárez
Dec 15, 2020·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Najeh HciniLéo Pomar
Dec 22, 2020·Free Radical Biology & Medicine·Wanyi FangJun Wang
Feb 4, 2021·Hepatology International·Fernanda Manhães PozzobonMaria Chiara Chindamo
Dec 3, 2020·Risk Management and Healthcare Policy·Nandeeta SamadMainul Haque
Feb 13, 2021·International Journal of Environmental Research and Public Health·Christian ZanzaRaffaele La Russa
Nov 17, 2020·Aging Clinical and Experimental Research·Francesco BolzettaNicola Veronese
Dec 17, 2020·Radiology·Pamela K Woodard
Jan 10, 2021·Immunology Letters·Claudio NapoliMariangela Rusciano
Feb 17, 2021·American Journal of Otolaryngology·Yuce IslamogluMuzaffer Kiris
Oct 26, 2020·Thrombosis and Haemostasis·Sam SchulmanStavros Konstantinides
Nov 3, 2020·Frontiers in Immunology·Dmitri SviridovMichael Bukrinsky
Jan 6, 2021·Archives of Pharmacal Research·Choongho Lee, Won Jun Choi
Jan 12, 2021·Case Reports in Infectious Diseases·Vincent PeykoAnthony Cutrona
Feb 21, 2021·Microbial Pathogenesis·Dounia DarifKhadija Akarid
Feb 12, 2021·Journal of Biomedical Informatics·Rui ZhangHalil Kilicoglu
Feb 27, 2021·Critical Care : the Official Journal of the Critical Care Forum·Erik ZetterstenEmma Larsson
Feb 17, 2021·Critical Care Medicine·Craig M CoopersmithDaniel De Backer
Apr 4, 2021·Journal of Clinical Medicine·Mohammad Suhail AkhterArijit Biswas
Apr 2, 2021·Disease Markers·Fátima Higuera-de-la-TijeraJosé L Pérez-Hernández
Apr 15, 2021·Postgraduate Medical Journal·Atanu ChandraSugata Dasgupta
Apr 28, 2021·Rheumatology International·Hussain Ahmed RazaLatika Gupta
Apr 26, 2021·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Tarab MansoorOmar Hussein
May 1, 2021·International Journal of Environmental Research and Public Health·Gabriele MelegariAlberto Barbieri
Apr 8, 2021·Journal of Thrombosis and Haemostasis : JTH·Ganeem K JunejaUNKNOWN COVID-BEACONS investigators
May 3, 2021·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Keith J Kincaid, Alexis N Simpkins
Jun 3, 2021·Journal of Clinical Medicine·Victor ArévalosSalvatore Brugaletta
May 18, 2021·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Christian SalbachEvangelos Giannitsis
Jun 3, 2021·Annals of Medicine and Surgery·Ghizlane El AidouniBrahim Housni
May 18, 2021·Respiratory Medicine Case Reports·Sakir AkinTim Jansen
Jun 3, 2021·Viruses·Yesha H ParekhPayal D Parikh
Jun 18, 2021·Critical Care Medicine·Rolf Dembinski
Jun 25, 2021·A&A Practice·Elba da Paixão RodriguesMarcos Adriano Lessa
Jul 3, 2021·Journal of Community Hospital Internal Medicine Perspectives·Sharon Desales BaoasMichael Zenilman
Jul 3, 2021·Journal of Community Hospital Internal Medicine Perspectives·Moaaz BaghalAbraham Lo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Cleveland Clinic Journal of Medicine
Anup Katyal
American Journal of Respiratory Cell and Molecular Biology
Ken-Ichiro InoueHirohisa Takano
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Stephanie G LeeMichelle Sholzberg
© 2021 Meta ULC. All rights reserved